Sangam: A Confluence of Knowledge Streams

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial

Show simple item record

dc.creator McMillan, AK
dc.creator Phillips, EH
dc.creator Kirkwood, AA
dc.creator Barrans, S
dc.creator Burton, C
dc.creator Rule, S
dc.creator Patmore, R
dc.creator Pettengell, R
dc.creator Ardeshna, KM
dc.creator Lawrie, A
dc.creator Montoto, S
dc.creator Paneesha, S
dc.creator Clifton-Hadley, L
dc.creator Linch, DC
dc.date 2022-03-03T13:46:22Z
dc.date 2020-09
dc.date.accessioned 2022-05-26T21:09:18Z
dc.date.available 2022-05-26T21:09:18Z
dc.identifier 0923-7534
dc.identifier http://hdl.handle.net/10026.1/18873
dc.identifier 10.1016/j.annonc.2020.05.016
dc.identifier.uri http://localhost:8080/xmlui/handle/CUHPOERS/228910
dc.format 1251 - 1259
dc.language en
dc.language en
dc.publisher Elsevier
dc.relation ISSN:0923-7534
dc.rights 2022-03-09
dc.rights Not known
dc.title Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial
dc.type Journal Article


Files in this item

Files Size Format View
PIIS0923753420398379.pdf 502.9Kb application/pdf View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse